ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly cash and cash equivalents ($M) ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2025
7,268
Period ended Dec 31, 2025
Change on a year earlier
+122.4%
3,268 in FY2024
History
20 years
Since FY2006
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash and cash equivalents ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,268 | +122.4% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 3,268 | +15.9% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 2,819 | +36.4% | Form 10-K (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 2,067 | -45.9% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 3,819 | +4.4% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 3,657 | +56.5% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 2,338 | -68.1% | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 7,321 | +12.0% | Form 10-Q (filed 2019-05-02) ↗ |
| FY2017 | Dec 31, 2017 | 6,536 | +42.6% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 4,582 | +25.0% | Form 10-K (filed 2017-02-21) ↗ |
| FY2015 | Dec 31, 2015 | 3,666 | -5.3% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 3,872 | +1.1% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 3,830 | -4.7% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 4,019 | -32.1% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 5,923 | -1.2% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | 5,993 | +34.3% | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 4,463 | -18.8% | Form 10-K (filed 2010-02-22) ↗ |
| FY2008 | Dec 31, 2008 | 5,497 | +70.7% | Form 10-Q (filed 2009-07-31) ↗ |
| FY2007 | Dec 31, 2007 | 3,221 | +3.6% | Form 10-Q (filed 2009-07-31) ↗ |
| FY2006 | Dec 31, 2006 | 3,109 | – | Form 10-K (filed 2010-02-22) ↗ |
Cite this data
StockData. (2026). Eli Lilly Cash and cash equivalents ($M) ($M), annual FY2006–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_cash
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.